INSTITUTO DE BIOMEDICINA Y GENÉTICA MOLECULAR (IBGM)
Instituto
Wellcome Trust Sanger Institute
Cambridge, Reino UnidoPublicaciones en colaboración con investigadores/as de Wellcome Trust Sanger Institute (11)
2023
2022
-
A first update on mapping the human genetic architecture of COVID-19
Nature
-
Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)
Nature
-
Stroke genetics informs drug discovery and risk prediction across ancestries
Nature, Vol. 611, Núm. 7934, pp. 115-123
-
Whole-genome sequencing reveals host factors underlying critical COVID-19
Nature, Vol. 607, Núm. 7917, pp. 97-103
2021
-
Mapping the human genetic architecture of COVID-19
Nature, Vol. 600, Núm. 7889, pp. 472-477
2017
-
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer
Nature Genetics, Vol. 49, Núm. 5, pp. 680-691
2016
-
Chemokine (C-C Motif) Receptor 2 Mediates Dendritic Cell Recruitment to the Human Colon but Is Not Responsible for Differences Observed in Dendritic Cell Subsets, Phenotype, and Function Between the Proximal and Distal Colon
Cellular and Molecular Gastroenterology and Hepatology, Vol. 2, Núm. 1, pp. 22-39.e5
2015
1999
-
The hairless gene of the mouse: Relationship of phenotypic effects with expression profile and genotype
Developmental Dynamics, Vol. 216, Núm. 2, pp. 113-126